Kala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Go back to Kala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
(NASDAQ: KALA) Delayed: 0.91 -0.04 (4.21%)
Previous Close $0.95    52 Week High
Open $0.95    52 Week Low
Day High $1.00    P/E N/A 
Day Low $0.90    EPS
Volume 117,990